Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Current Urology Reports
Erschienen in: Current Urology Reports 9/2014

01.09.2014 | Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Bladder Outlet Obstruction in Women: Functional Causes

verfasst von: Ashley B. King, Howard B. Goldman

Erschienen in: Current Urology Reports | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Bladder outlet obstruction (BOO) in women has received less focus in the past, as compared with BOO in men; however, more recently, studies have further examined BOO and voiding dysfunction in women to define the various etiologies, diagnostic criteria, and treatment strategies. The differential diagnosis in women is broad and includes anatomic, neurologic, and functional etiologies. This review focuses on the functional etiologies, including dysfunctional voiding, Fowler’s syndrome, and primary bladder neck obstruction in adult women.
Literatur
1.
Haylen B, Ridder D, Freeman R, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) Joint Report on the Terminology for Female Pelvic Floor Dysfunction. Neurourol Urodyn. 2010;29:4–20.PubMed
2.••
Tanagho E, Miller E, Meyers F, Corbett R. Observations on the dynamics of the bladder neck. BJU Int. 1966;38:72–84. Important early work on normal micturition.CrossRef
3.••
Tanagho E, Miller E. Initiation of voiding. BJU Int. 1970;42:175–83. Important early work on normal micturition.CrossRef
4.
Nager C, Albo M, Fitzgerald M, McDermott S, Wruck L, Kraus S, et al. Reference urodynamic values for stress incontinent women. Neurourol Urodyn. 2007;26:333–40.PubMedCrossRef
5.
Defreitas G, Zimmern P, Lemack G, Shariat S. Refining diagnosis of anatomic female bladder outlet obstruction: comparison of pressure flow study parameters in clinically obstructed women with those of normal controls. Urology. 2004;64:675.PubMedCrossRef
6.
Chassange S, Bernier P, Haab F, Roehrborn C, Reisch J, Zimmern P. Proposed cutoff values to define bladder outlet obstruction in women. Urology. 1998;51:408.CrossRef
7.
Lemack G, Zimmern P. Pressure flow analysis may aid in identifying women with outflow obstruction. J Urol. 2000;163:1823.PubMedCrossRef
8.
Blaivas J, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19:553.PubMedCrossRef
9.
Nitti V, Tu L, Gitlin J. Diagnosing bladder outlet obstruction in women. J Urol. 1999;161:1535.PubMedCrossRef
10.•
Akikwala T, Fleischman N, Nitti V. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol. 2006;176:2093–7. Useful in analyzing parameters of bladder outlet obstruction in women.PubMedCrossRef
11.••
Hinman F, Baumann F. Vesical and ureteral damage from voiding dysfunction in boys without neurologic or obstructive disease. J Urol. 1973;109:727–32. Original paper describing Hinman’s syndrome.PubMed
12.••
Allen T, Bright T. Urodynamic patterns in children with dysfunctional voiding problems. J Urol. 1978;119:247–9. Original description of dysfunctional voiding.PubMed
13.
Raz S, Smith R. External sphincter spasticity syndrome in female patients. J Urol. 1976;115:443–6.PubMed
14.
Minassian V, Lovatsis D, Pascali D, Alarab M, Drutz H. Effect of childhood dysfunctional voiding on urinary incontinence in adult women. Obstet Gynecol. 2006;107:1247–51.PubMedCrossRef
15.
Groutz A, Blaivas J, Pies C, Sassone A. Learned voiding dysfunction (non-neurogenic neurogenic bladder) among adults. Neurourol Urodyn. 2001;20:259–68.PubMedCrossRef
16.
Fan Y, Lin A, Wu H, Hong C, Chen K. Psychological profile of female patients with dysfunctional voiding. Urology. 2008;71:625–9.PubMedCrossRef
17.
Bellina J, Schenck D, Millet A, Denicola C, Kelly R, Cook A. Outflow uropathy: occupational disorder? J La State Med Soc. 1999;151:414–9.PubMed
18.
McGuire E, Savastano J. Urodynamic studies in enuresis and the nonneurogenic neurogenic bladder. J Urol. 1984;132:299.PubMed
19.
Xu D, Qu C, Ren J, Jiang H, Yao Y, Min Z, et al. Impact of tension free vaginal tape procedure on dysfunctional voiding in women with stress urinary incontinence. Int J Urol. 2010;17:346–52.PubMed
20.
21.
Chen Y, Kuo H. Clinical and video urodynamic characteristics of adult women with dysfunctional voiding. J Formos Med Assoc. 2014;113:161–5.PubMedCrossRef
22.
Van Nieuwkoop C, Voorham-van der Zam P, Van Laar A, et al. Pelvic floor dysfunction is not a risk factor for febrile urinary tract infection in adults. BJU Int. 2010;105:1689–95.PubMedCrossRef
23.
Minardi D, D’Anzeo G, Parri G, Polito M, Piergallina M, Asmar Z, et al. The role of uroflowmetry biofeedback and biofeedback training of the pelvic floor muscles in the treatment of recurrent urinary tract infections in women with dysfunctional voiding: a randomized controlled prospective study. Urology. 2010;75:1299–304.PubMedCrossRef
24.
Mabry E, Carson C, Older R. Evaluation of women with chronic voiding discomfort. Urology. 1998;18:244.CrossRef
25.
Tanagho E, Miller E, Lyon R, Fisher R. Spastic striated external sphincter and urinary tract infection in girls. BJU Int. 1971;43:69–82.CrossRef
26.•
Deindl F, Vodusek D, Bischoff C, Hofmann R, Hartung R. Dysfunctional voiding in women: which muscles are responsible? B J Urol. 1998;82:814–9. Important in diagnosis of dysfunctional voiding.
27.
Minardi D, Parri G, D’Anzeo G, Fabiani A, Asmar Z, Muzzonigro G. Perineal ultrasound evaluation of dysfunctional voiding in women with recurrent urinary tract infection. J Urol. 2008;179:947–51.PubMedCrossRef
28.
Rogalski M, Kellogg-Spadt S, Hoffmann A, Fariello J, Whitmore K. Retrospective chart review of vaginal diazepam suppository use in high-tone pelvic floor dysfunction. Int Urogynecol J. 2010;21:895–9.PubMedCrossRef
29.•
Xu D, Chuangyu Q, Meng H, Ren J, Zhu Y, Min Z, et al. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial. BJU Int. 2007;100:588–92. Well-designed trial looking at the effect of baclofen on dysfunctional voiding.PubMedCrossRef
30.
Phelan M, Franks M, Somogyi G, Yokoyama T, Fraser M, Lavelle J, et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol. 2001;165:1107–10.PubMedCrossRef
31.
Roth T, Vandersteen D, Hollatz P, Inman B, Reinberg Y. Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children. J Urol. 2008;180:306–11.PubMedCrossRef
32.••
Fowler C et al. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ. 1988;297:1436–8. Original paper describing Fowler’s syndrome.PubMedCentralPubMedCrossRef
33.
Osman N, Chapple C. Fowler’s syndrome—a cause of unexplained urinary retention in young women? Nat Rev Urol. 2014;11:87–98.PubMedCrossRef
34.
Amarenco G, Raibaut P, Ismael S, Rene-Corail P, Haab F. Evidence of occult dysautonomia in Fowler’s syndrome: alteration of cardiovascular autonomic function tests in female patients presenting with urinary retention. BJU Int. 2006;97:288–91.PubMedCrossRef
35.
Mayer E, Naliboff B, Craig A. Neuroimaging of the brain-gut-axis: from basic understanding to treatment of functional GI disorders. Gastroenterology. 2006;131:1925–42.PubMedCrossRef
36.
37.
DeGroat W, Fraser M, Yoshiyama M, et al. Neural control of the urethra. Scand J Urol Nephrol Suppl. 2001;207:35.CrossRef
38.•
DasGupta R, Critchley H, Dolan R, Fowler C. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005;174:2268–72. Aids in understanding of the effect of sacral neuromodulation in women.PubMedCrossRef
39.
DasGupta R, Fowler C. Urodynamic study of women in urinary retention treated with sacral neuromodulation. J Urol. 2004;171:1161–4.PubMedCrossRef
40.
Kavia R, DasGupta R, Critchley H, Fowler C, Griffiths D. A functional magnetic resonance imaging study of the effect of sacral neuromodulation on brain responses in women with Fowler’s syndrome. BJU Int. 2009;105:366–72.PubMedCrossRef
41.
Swinn M, Wiseman O, Lowe E, Fowler C. The cause and natural history of isolated urinary retention in young women. J Urol. 2002;167:151–6.PubMedCrossRef
42.
Duijkers I, Klipping C. Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women. Gynecol Endocrinol. 2010;26:152–60.PubMedCrossRef
43.
Goodwin R, Swinn M, Fowler C. The neurophysiology of urinary retention in young women and its treatment by neuromodulation. World J Urol. 1998;16:305–7.PubMedCrossRef
44.
Burnett K, Tawadros C, Derbyshire L, Clarke N, Betts C. External urethral sphincter electromyographic activity (EMG) in asymptomatic women and the influence of the menstrual cycle…more questions than answers. BJU Int. 2013;111:52.
45.
Ramm O, Mueller E, Brubaker L, Lowensteing L, Kenton K. Complex repetitive discharges—a feature of the urethral continence mechanism or a pathological finding? J Urol. 2012;187:2140–3.PubMedCrossRef
46.
Kujawa M, Reid F, Elis A, Clarke N, Betts C. Are “whaling” women normal. BJU Int. 2001;88:82.
47.
Wiseman O, Swinn M, Brady C, Fowler C. Maximum urethral closure pressure and sphincter volume in women with urinary retention. J Urol. 2002;167:1348–52.PubMedCrossRef
48.
Andrich D, Rickards D, Landon D, Fowler C. Structural assessment of the urethral sphincter in women with urinary retention. J Urol. 2005;171:1161–4.
49.
Fowler C, Betts C, Christmas T, et al. Botulinum toxin in the treatment of chronic urinary retention in women. BJU Int. 1992;70:387–9.CrossRef
50.
DasGupta R, Wiseman O, Kitchen N, Fowler C. Long-term results of neuromodulation for women with urinary retention. BJU Int. 2004;94:335–7.PubMedCrossRef
51.
Swinn M, Kitchen N, Goodwin R, Fowler C. Sacral neuromodulation for women with Fowler’s syndrome. Eur Urol. 2000;38:439–43.PubMedCrossRef
52.
Groen L, Hoebeke P, Loret N, Van Praet C, Van Laeke E, Ann R, et al. Sacral neuromodulation with an implantable pulse generator in children with lower urinary tract symptoms: 15-Year Experience. J Urol. 2012;188:1313–8.PubMedCrossRef
53.
Peeters K, Sahai A, DeRidder D, Van Der Aa F. Long term follow up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int. 2014;113:789–94.PubMedCrossRef
54.
55.
Khunda A, Karmarkar R, Abtahi B, Gonzales G, Elneil S. Pregnancy in women with Fowler’s syndrome treated with sacral neuomodulation. Int Urogynecol J. 2013;24:1201–4.PubMedCrossRef
56.
Leadbetter G, Leadbetter W. Diagnosis and treatment of congenital bladder-neck obstruction in children. NEJM. 1959;260:633–7.PubMedCrossRef
57.
Diokno A, Hollander J, Bennett C. Bladder neck obstruction in women: a real entity. J Urol. 1984;132:294–8.PubMed
58.
Turner-Warwick R, Whiteside C, Worth P, Milroy E, Bates C. A urodynamic view of the clinical problems associated with bladder neck dysfunction and its treatment by endoscopic incision and trans-trigonal posterior prostatectomy. BJU Int. 1973;45:44–59.CrossRef
59.
Yalla S, Resnik N. Initiation of voiding in humans: the nature and temporal relationship of urethral sphincter responses. J Urol. 1997;157:590–5.PubMedCrossRef
60.
Crowe R, Noble J, Robson T, et al. An increase in neuropeptide Y but not nitric oxide synthase-immunoreactive nerves in the bladder from male patients with bladder neck dyssynergia. J Urol. 1995;154:1231–6.PubMedCrossRef
61.
Kuo H. Videourodynamic characteristics and lower urinary tract symptoms of female bladder outlet obstruction. Urology. 2005;6:1005–9.CrossRef
62.
63.•
Brucker B, Fong E, Shah S, Kelly C, Rosenblum N, Nitti V. Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology. 2012;80:55–60. Useful in the differentiation of dysfunctional voiding and primary bladder neck obstruction.PubMedCrossRef
64.
Hickling D, Aponte M, Nitti V. Evaluation and management of outlet obstruction in women without anatomical abnormalities on physical exam or cystoscopy. Curr Urol Rep. 2012;13:356–62.PubMedCrossRef
65.
Lee K, Han D, Lee Y, Choo M, Yoo T, Park H, et al. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study. J Korean Med Sci. 2010;25:117–22.PubMedCentralPubMedCrossRef
66.
Kessler T, Studer U, Burkhard F. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J Urol. 2006;176:1487–92.PubMedCrossRef
67.
Costantini E, Lazzeri M, Bini V, Zucchi A, Fioretti F, Frumenzio E, et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int. 2009;83:311–5.PubMedCrossRef
68.
Cisternino A, Zeccolini G, Calpista A, DeMarco V, Galetti T, Iafrate M, et al. Obstructive primary bladder neck disease: evaluation of the efficacy and safety of alpha-1 blockers. Urol Int. 2006;76:150–3.PubMedCrossRef
69.
Kumar A, Mandhani A, Gogoi S, Srivastava A. Management of functional bladder neck obstruction in women: use of alpha-blockers and pediatric resectoscope for bladder neck incision. J Urol. 1999;162:2061–5.PubMedCrossRef
70.
Blaivas J, Flisser A, Tash J. Treatment of primary bladder neck obstruction in women with transurethral resection of the bladder neck. J Urol. 2004;171:1172–5.PubMedCrossRef
71.••
Zhang P, Wu Z, Xu L, Yang Y, Zhang N, Zhang X. Bladder neck incision for female bladder neck obstruction: long-term outcomes. Urology. 2014;83:762–7. Largest series of women with PBNO undergoing TUIBN.PubMedCrossRef
72.
Markic D, Maricic A, Oguic R, Spanjol J, Rahelic D, Rubinic N, et al. Transurethral baldder neck incision in women with primary bladder neck obstruction. Wien Klin Wochenschr. 2014;126:217–22.PubMedCrossRef
73.
Peng C, Kuo H. Transurethral incision of bladder neck in treatment of bladder neck obstruction in women. Urology. 2005;65:275–8.PubMedCrossRef
74.
Jin X, Qu H, Liu H, Li B, Wang J, Zhang Y. Modified transurethral incision for primary bladder neck obstruction in women: a method to improve voiding function without urinary incontinence. Urology. 2012;79:310–3.PubMedCrossRef
Metadaten
Titel
Bladder Outlet Obstruction in Women: Functional Causes
verfasst von
Ashley B. King
Howard B. Goldman
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Current Urology Reports / Ausgabe 9/2014
Print ISSN: 1527-2737
Elektronische ISSN: 1534-6285
DOI
https://doi.org/10.1007/s11934-014-0436-z

Weitere Artikel der Ausgabe 9/2014

Current Urology Reports 9/2014 Zur Ausgabe

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Evaluation and Management of Post-Transurethral Resection of the Prostate Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

Management of Refractory OAB in the Non-Neurogenic Patient

Urothelial Cancer (A Sagalowsky, Section Editor)

Confocal Laser Endomicroscopy of Bladder and Upper Tract Urothelial Carcinoma: A New Era of Optical Diagnosis?

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

A Review of Lower Urinary Tract Symptoms in Patients with Parkinson’s Disease

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

The Evaluation and Management of Persistent Nocturia

Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)

UTIs in Patients with Neurogenic Bladder

Neu im Fachgebiet Urologie

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise